FLUMAZENIL Drug Patent Profile
✉ Email this page to a colleague
When do Flumazenil patents expire, and what generic alternatives are available?
Flumazenil is a drug marketed by Baxter Hlthcare Corp, Dr Reddys, Fresenius Kabi Usa, Hikma, Hikma Farmaceutica, Rising, Sagent Pharms, and Sandoz. and is included in nine NDAs.
The generic ingredient in FLUMAZENIL is flumazenil. There are four drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the flumazenil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Flumazenil
A generic version of FLUMAZENIL was approved as flumazenil by BAXTER HLTHCARE CORP on October 12th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLUMAZENIL?
- What are the global sales for FLUMAZENIL?
- What is Average Wholesale Price for FLUMAZENIL?
Summary for FLUMAZENIL
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 9 |
| Finished Product Suppliers / Packagers: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 136 |
| Clinical Trials: | 49 |
| Patent Applications: | 2,908 |
| Drug Prices: | Drug price information for FLUMAZENIL |
| DailyMed Link: | FLUMAZENIL at DailyMed |
Recent Clinical Trials for FLUMAZENIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Pusan National University Yangsan Hospital | N/A |
| Yonsei University | N/A |
| Daegu Catholic University Medical Center | N/A |
Pharmacology for FLUMAZENIL
| Drug Class | Benzodiazepine Antagonist |
Medical Subject Heading (MeSH) Categories for FLUMAZENIL
Anatomical Therapeutic Chemical (ATC) Classes for FLUMAZENIL
US Patents and Regulatory Information for FLUMAZENIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | FLUMAZENIL | flumazenil | INJECTABLE;INJECTION | 076755-002 | Oct 12, 2004 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sandoz | FLUMAZENIL | flumazenil | INJECTABLE;INJECTION | 077071-002 | May 3, 2005 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hikma | FLUMAZENIL | flumazenil | INJECTABLE;INJECTION | 076256-002 | Oct 12, 2004 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Dr Reddys | FLUMAZENIL | flumazenil | INJECTABLE;INJECTION | 076589-001 | Oct 12, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma Farmaceutica | FLUMAZENIL | flumazenil | INJECTABLE;INJECTION | 078527-002 | Mar 23, 2009 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hikma | FLUMAZENIL | flumazenil | INJECTABLE;INJECTION | 076787-002 | Oct 12, 2004 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
